19.08.2022 • NewsEvonik

Evonik to Expand Matting Agents in Taiwan

Evonik is expanding production capacity for its Acematt-branded matting agents at its site in Taiwan.

Without quantifying the size of the expansion, the company said the increase will be “significant” and will help to meet the rising demand for the coatings additives.

The new capacity is expected to be in the market during the second half of 2023. The German specialty chemicals producer said the matting agents manufactured in Taiwan exhibit the same properties as those made at its site in Bonn, Germany.

Evonik said the brand offers a variety of products to the coatings formulator, including finding the right balance of effectiveness for matting properties and easy integration into the coating system.

What’s more, the Essen-based chemical producer said Acematt products can enable formulators to reach the full spectrum of matting levels from semi-gloss to ultra-deep matt. Areas of application in industry and transportation range from textile to plastic, leather, can and coil coatings

“The capacity expansion of our leading matting agents in Taiwan further emphasizes our commitment to the growing markets in Asia and to all our regional and multi-national customers,” said Maximilian Morin, head of Industrial & Transportation Coatings at Evonik Coating Additives.

Morin said the company is continuously expanding its position as a global partner for the coatings industry by offering the same high quality products from manufacturing locations in multiple regions. Amid rising logistical challenges, such an investment will also directly help to improve the supply situation worldwide, he added.

Author: Dede Williams, Freelance Journalist

© Evonik
© Evonik

Company

Logo:

Evonik Technology & Infrastructure GmbH (Marl)

Paul-Baumann-Str. 1
45772 Marl
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read